PMID: 11337230May 5, 2001Paper

Mupirocin resistance among Malaysian isolates of methicillin-resistant Staphylococcus aureus

International Journal of Antimicrobial Agents
A NorazahV K Lim

Abstract

Four hundred methicillin-resistant Staphylococcus aureus strains (MRSA) from different geographical areas in Malaysia were tested for mupirocin susceptibility using minimum inhibitory concentration (MIC) determination. The majority of these strains (98.75%) were susceptible to mupirocin with MICs of < or = 4 mg/l. Fifty-percent of these strains had MICs of 0.125 mg/l or less while 90% of the strains had MICs of 1 mg/l or less. Mupirocin resistance was detected in five strains (1.25%) and one of these (0.25%) had an MIC of 64 mg/l and the other four strains (1%), high-level resistance with MICs > 512 mg/l. Even though the rate of mupirocin resistance in MRSA is still low in Malaysia, its presence calls for a strict policy on mupirocin usage in Malaysian hospitals.

References

May 5, 1990·Lancet·B D CooksonR J Redhead
Apr 1, 1989·Epidemiology and Infection·M RahmanB Cookson
May 1, 1985·The Journal of Antimicrobial Chemotherapy·M W Casewell, R L Hill
Sep 1, 1994·The Journal of Hospital Infection·S J DawsonD A Lewis
Nov 1, 1994·Diagnostic Microbiology and Infectious Disease·L J UtrupJ A Poupard
Jan 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R CoelloC Gaspar
Dec 1, 1996·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M A MillerJ Mendelson

❮ Previous
Next ❯

Citations

May 21, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Hamed Ghasemzadeh-MoghaddamVasanthakumari Neela
Jan 24, 2007·Diagnostic Microbiology and Infectious Disease·Ravisekhar GadepalliJ C Samantaray
Dec 9, 2015·Journal of Research in Pharmacy Practice·Loveleena AgarwalAmitabh Agarwal
Jun 6, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Nabin K ShresthaGary W Procop
Aug 24, 2019·Journal of Global Antimicrobial Resistance·Masoud DadashiMehdi Goudarzi
Dec 16, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Saeed KhoshnoodMahtab Abdi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.